studi
conduct
exclus
sir
albert
sakzewski
viru
research
centr
royal
children
hospit
health
servic
brisban
queensland
australia
necessari
ethic
approv
studi
obtain
ethic
committe
royal
children
hospit
specimen
test
studi
n
collect
januari
decemb
pediatr
patient
birth
year
age
n
age
rang
year
mean
year
median
year
adult
patient
n
age
rang
year
mean
year
median
year
hospit
sought
treatment
hospit
queensland
australia
upper
lower
respiratori
tract
symptom
sampl
nasopharyng
aspir
npa
remaind
bronchoalveolar
lavag
specimen
bronchial
wash
specimen
endotrach
aspir
sampl
collect
part
previou
studi
test
influenza
virus
b
adenovirus
human
metapneumoviru
respiratori
syncyti
viru
parainfluenza
virus
addit
kipyv
wupyv
sampl
screen
use
mcpyv
realtim
pcr
specif
region
briefli
pmol
primer
pmol
duallabel
probe
reaction
use
qiagen
quantitect
probe
master
mix
qiagen
doncast
victoria
australia
templat
run
lightcycl
roch
diagnost
castl
hill
new
south
wale
australia
follow
condit
incub
min
follow
cycl
min
quantit
realtim
pcr
perform
limit
applic
due
inher
variabl
respiratori
sampl
collect
presenc
mcpyv
sampl
posit
realtim
pcr
confirm
use
partial
larg
antigen
major
capsid
protein
convent
mcpyv
detect
pcr
assay
feng
et
al
pcr
perform
unidirect
workflow
dedic
suit
reagent
prepar
pcr
setup
amplif
ten
random
realtim
sampl
water
control
sampl
templateneg
control
sampl
use
exclud
amplicon
sampl
crosscontamin
clinic
sampl
posit
mcpvv
assay
confirm
sequenc
use
posit
control
pcr
thirtyon
sampl
produc
posit
result
realtim
pcr
screen
could
confirm
convent
pcr
yield
posit
result
mcpyv
pcr
posit
detect
npa
sampl
variat
detect
rate
could
due
unforeseen
nonspecif
realtim
pcr
inher
lower
sensit
convent
pcr
realtim
sampl
produc
late
signal
cycl
threshold
valu
chose
conserv
algorithm
sampl
must
posit
assay
consid
true
posit
rule
may
led
underestim
mcpyv
preval
sampl
popul
mcpyvposit
sampl
collect
spring
earli
summer
month
five
sampl
origin
pediatr
patient
suggest
earli
acquisit
viru
fact
mcpyvposit
patient
immunosuppress
year
age
tabl
age
rang
coincid
age
experi
primari
infect
mani
human
virus
immunosupress
mcpyvposit
patient
adult
child
inform
mcpyvposit
patient
list
tabl
could
discern
whether
higher
frequenc
detect
adult
repres
gener
adult
popul
whether
detect
overrepres
due
small
sampl
size
immun
statu
adult
cohort
integr
statu
detect
mcpyv
dna
abl
ascertain
howev
patient
multipl
sampl
test
mcpyv
neither
detect
month
month
detect
suggest
least
particular
patient
mcpyv
may
transitori
presenc
activ
multipl
sampl
avail
mcpyvposit
patient
three
mcpyv
sampl
investig
bidirect
sequenc
respect
respect
assay
amplif
product
sequenc
sampl
show
high
homolog
previous
describ
mcpyv
strain
sequenc
similar
target
region
rang
respect
tabl
clinic
note
avail
mcpyvposit
patient
indic
patient
exhibit
varieti
upper
lower
respiratori
tract
symptom
mcpyv
sole
viral
agent
detect
sampl
tabl
howev
due
limit
remain
volum
studi
sampl
screen
known
respiratori
pathogen
includ
coronavirus
rhinovirus
may
led
higher
codetect
rate
similar
kipyv
wupyv
date
mcpyv
commonli
studi
detect
context
merkel
cell
carcinoma
also
identifi
kaposi
sarcoma
tissu
primari
squamou
cell
carcinoma
tissu
keratoacanthoma
tissu
organ
recipi
normal
sunexpos
skin
small
number
control
tissu
normal
skin
small
bowel
hemorrhoid
appendix
gall
bladder
studi
mcpyv
detect
respiratori
sampl
collect
symptomat
person
descript
presenc
mcpyv
respiratori
tract
rais
question
transmiss
respiratori
pathogen
newli
describ
pyv
analog
mcpyv
kipyv
wupyv
found
global
respiratori
specimen
high
preval
codetect
virus
clear
evid
causal
associ
respiratori
ill
yet
identifi
pyv
may
mere
transmit
respiratori
rout
detect
period
reactiv
similarli
jc
bk
pyv
suspect
transmit
inhal
occasion
detect
respiratori
sampl
yet
patient
gener
remain
asymptomat
exhibit
nonspecif
upper
respiratori
tract
symptom
like
pyv
mcpyv
may
potenti
transmit
respiratori
rout
becom
latent
site
epiderm
tissu
system
spread
similar
fashion
murin
pyv
clearli
studi
use
larger
sampl
popul
expand
respiratori
pathogen
detect
method
control
group
need
elucid
role
mcpyv
play
upper
lower
respiratori
tract
ill
basi
age
immun
statu
mcpyvposit
patient
hypothes
mcpyv
may
infecti
cycl
similar
human
pyv
viru
acquir
earli
life
undergo
period
latenc
becom
reactiv
event
immunosuppress
sequenc
data
posit
specimen
indic
mcpyv
found
respiratori
secret
similar
virus
identifi
within
merkel
cell
carcinoma
whether
viru
translat
respiratori
tract
skin
cell
abl
transport
system
role
malign
transform
merkel
cell
question
worthi
investig
